Pregnancy and COVID‐19: pharmacologic considerations

In this review, we summarize evidence regarding the use of routine and investigational pharmacologic interventions for pregnant and lactating patients with coronavirus disease 2019 (COVID‐19). Antenatal corticosteroids may be used routinely for fetal lung maturation between 24 and 34 weeks' ges...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Souza, R., Ashraf, R., Rowe, H., Zipursky, J., Clarfield, L., Maxwell, C., Arzola, C., Lapinsky, S., Paquette, K., Murthy, S., Cheng, M. P., Malhamé, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2021
Materias:
State‐of‐the‐Art Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537532/
https://www.ncbi.nlm.nih.gov/pubmed/32959455
http://dx.doi.org/10.1002/uog.23116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537532/
https://www.ncbi.nlm.nih.gov/pubmed/32959455
http://dx.doi.org/10.1002/uog.23116

Ejemplares similares